Effect of serotonin on plasma aldosterone in man

  • Franco Mantero
  • G. Opocher
  • M. Boscaro
  • D. Armanini
Article
First Online:
Received:
Accepted:

Abstract

Serotonin (5HT) is known to be one of the most active aldosterone-stimulating substances in rat adrenal tissue, but its effect in vivo has been scarcely investigated, especially in man. We have studied the effect of an infusion of 5HT in 14 normal subjects. Plasma aldosterone significantly increased during 5HT infusion, while Cortisol and plasma renin activity were not modified. No changes in serum K, blood pressure or heart rate were noticed. These data suggest that 5HT may influence aldosterone secretion also in man.

Key-words

Serotonin aldosterone 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Müller J., Ziegler W.H. Stimulation of aldosterone biosynthesis in vitro by serotonin. Acta Endocrinol. (Kbh.) 39: 23, 1968.Google Scholar
  2. 2.
    Espiner E.A., Al-Dujaili E.A.S., Martin V.I., Edwards C.R.W. Indoloamines stimulates steroidogenesis in isolated human adrenal cells. Proceedings 6th International Congress of Endocrinology, Melbourne 10–12 february 1980, p. 593 (abstract).Google Scholar
  3. 3.
    Farrel G., Mc Isaac W.M. Adrenoglomerulotropin. Arch. Biochem. Biophys. 94: 543, 1961.CrossRefGoogle Scholar
  4. 4.
    Blair-West J.R., Coghlan J.P., Denton D.A., Goding J.R., Munro J.A., Peterson R.E., Wintour M. Hormonal stimulation of adrenocortical secretion. J. Clin. Invest. 41: 1606, 1962.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Modlinger R.S., Shonmuller J.M., Arora S.P. Stimulation of aldosterone, renin and Cortisol by tryptophan. J. Clin. Endocrinol. Metab. 48: 599, 1979.PubMedCrossRefGoogle Scholar
  6. 6.
    Boscaro M., Al-Dujaili E.A.S., Edwards C.R.W. In vitro studies on the mechanism of inhibition by bromocriptine, lisuride and metergoline of angiotensin II induced aldosterone release. Acta Endocrinol. (Khb.) 91 (Suppl. 255): 343, 1979 (abstract).Google Scholar
  7. 7.
    Stockigt J.R., Collins R.D., Biglieri E.G. Determination of plasma renin concentration by angiotensin I radioimmunoassay: diagnostic import of precise measurement of subnormal renin in hyperaldosteronism. Circ. Res. (Suppl.) 2: 175, 1971.Google Scholar
  8. 8.
    Goodman L.S., Gilman A. The pharmacological basis of therapeutics, ed. 5. Mac Millan Publishing Co. Inc., New York, 1975, p. 614.Google Scholar
  9. 9.
    Douglas W.W., Kanno T., Sampson S.R. Effects of acetylcholine and other medutlary secreta-gogues and antagonists on the membrane potential of adrenal chromaffin cells: an analysis employing techniques of tissue culture. J. Physiol. (Lond.) 788: 107, 1967.Google Scholar
  10. 10.
    Somlyo A.P., Somlyo A.V. Vascular smooth muscle II. Pharmacology of normal and hypertensive vessel. Pharmacol. Rev. 22: 249, 1970.PubMedGoogle Scholar
  11. 11.
    Bevilacqua M., Norbiato G., Raggi U., Micossi P., Baggi E., Prandelli M. Dopaminegic control of serum potassium. Metabolism 29: 306, 1980.PubMedCrossRefGoogle Scholar
  12. 12.
    Gross M.D., Grekin R.J., Gniadek T.C., Villareal J.Z. Suppression of aldosterone by cyproheptadine in idiopathic aldosteronism. N. Engl. J. Med. 305: 181, 1981.PubMedCrossRefGoogle Scholar
  13. 13.
    Mantero F., Boscaro M., Opocher G., Armanini G., Edwards C.R.W. Effetti della metergolina sulla secrezione di aldosterone: studi in vivo e in vitro. J. Endocrinol. Invest. 1 (Suppl. 4): 243, 1981.Google Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1982

Authors and Affiliations

  • Franco Mantero
    • 1
  • G. Opocher
    • 1
  • M. Boscaro
    • 1
  • D. Armanini
    • 1
  1. 1.Istituto di Semeiotica MedicaUniversità di PadovaPadovaItaly

Personalised recommendations